| Swine Flu ADR Portal
With the increased usage of antiviral medicines (tamiflu and relenza) for the treatment of swine flu the MHRA has put place measures to monitor the safety of these important medicines. Suspected side effects to antivirals, and when available H1N1 swine flu vaccines, should be reported via a dedicated internet-based reporting system, the ‘Swine Flu ADR Portal’. The MHRA has developed this Portal to sit alongside the Yellow Card Scheme and act as the main channel through which healthcare professionals and patients/carers can report suspected side effects.
Yellow Card Centre West Midlands is one of the regional centres of the Medicines and Healthcare products Regulatory Agency. Our centre is based within City Hospital, Birmingham. We are responsible for education and research concerned with Yellow Card reporting - one of the primary ways of discovering new adverse drug reactions to medicines and herbal products. (Yellow Cards) from within the area covered by West Midlands Strategic Health Authority. Wepublish an occasional bulletin, re:Action, and staff lecture throughout the Region on adverse drug reactions to doctors, dentists, nurses, pharmacists and other healthcare professionals. We are also happy to talk to patient groups. Patients can provide important insight into adverse drug reactions and are now able to report directly to the MHRA via the website and a freephone number 0808 100 3352. We cannot accept direct enquiries from the public. If you would like our group to arrange a talk on adverse drug reactions and the Yellow Card scheme, please Contact us. Other Yellow Card Centres are based in Cardiff (for Wales), Liverpool (for the Mersey region), Newcastle upon Tyne (for Northern and Yorkshire region), and Edinburgh (for Scotland). This site includes data from the medicalliterature and from licensing authorities and drug safety agencies around theworld. Doctors in the United Kingdom should follow the advice of the Medicinesand Healthcare products Regulatory Agency. In case of doubt, go to www.mhra.gov.uk
|